Clearside Biomedical Announces Advancement of XIPERE in Asia-Pacific for Suprachoroidal Treatment of Uveitic Macular Edema as Partner Arctic Vision Completes Enrollment in Phase 3 Clinical Trial in China
CLSD Stock | USD 0.86 0.03 3.37% |
About 63% of all Clearside Biomedical's shareholders are looking to take a long position. The analysis of overall sentiment of trading Clearside Biomedical stock suggests that some investors are interested at this time. The current market sentiment, together with Clearside Biomedical's historical and current headlines, can help investors time the market. In addition, many technical investors use Clearside Biomedical stock news signals to limit their universe of possible portfolio assets.
Clearside |
- Continued Progress in the Global Development and Commercialization of XIPERE - ALPHARETTA, Ga., Oct. 04, 2023 -- Clearside Biomedical, Inc. , a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space , announced that Arctic Vision, Clearsides partner, has successfully completed enrollment in its Phase 3 randomized, double-blind, placebo-controlled clinical tri
Read at finance.yahoo.com
![]() |
Clearside Biomedical Current Investor Sentiment
Comfort Level 63
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Clearside Biomedical's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Clearside Biomedical.
News SentimentBullish | Hype SentimentBearish | Insider SentimentAcquiring |
Clearside Biomedical Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Clearside Biomedical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Clearside Biomedical Fundamental Analysis
We analyze Clearside Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clearside Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clearside Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
Clearside Biomedical is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Clearside Biomedical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Clearside Biomedical stock to make a market-neutral strategy. Peer analysis of Clearside Biomedical could also be used in its relative valuation, which is a method of valuing Clearside Biomedical by comparing valuation metrics with similar companies.
Peers
Clearside Biomedical Related Equities
DRTS | Alpha Tau | 9.03 | ||||
SNSE | Sensei Biotherapeutics | 6.82 | ||||
ERAS | Erasca | 6.20 | ||||
INBX | Inhibrx | 5.16 | ||||
LYRA | Lyra Therapeutics | 5.00 | ||||
CCCC | C4 Therapeutics | 4.23 | ||||
DSGN | Design Therapeutics | 3.85 | ||||
OCUL | Ocular Therapeutix | 2.88 | ||||
ORIC | Oric Pharmaceuticals | 2.42 | ||||
KRON | Kronos Bio | 2.08 | ||||
NXTC | NextCure | 1.32 | ||||
GLUE | Monte Rosa | 0.92 | ||||
NUVB | Nuvation Bio | 0.51 | ||||
EWTX | Edgewise Therapeutics | 0.83 | ||||
INZY | Inozyme Pharma | 0.83 | ||||
TNYA | Tenaya Therapeutics | 0.99 | ||||
EPIX | ESSA Pharma | 1.18 | ||||
EYEN | Eyenovia | 1.74 | ||||
GBIO | Generation Bio | 3.57 |
Complementary Tools for Clearside Stock analysis
When running Clearside Biomedical's price analysis, check to measure Clearside Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearside Biomedical is operating at the current time. Most of Clearside Biomedical's value examination focuses on studying past and present price action to predict the probability of Clearside Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearside Biomedical's price. Additionally, you may evaluate how the addition of Clearside Biomedical to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |